Causes of death in a post‐mortem series of ALS patients

Philippe Corcia(Centre Hospitalier Universitaire de Tours), Vincent Meininger(Générale de Santé), Danielle Seilhean(Inserm), Pierre‐François Pradat(Sorbonne Université), François Salachas(Sorbonne Université), Gaëlle Bruneteau(Centre National de la Recherche Scientifique), Jean‐Jacques Hauw(Sorbonne Université), Nadine Le Forestier(Sorbonne Université)
Amyotrophic Lateral Sclerosis
January 1, 2008
10.1080/17482960701656940
Cited by 180

Related Papers

A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
|New England Journal of Medicine|1994|2.2k
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
|Nature Genetics|2008|1.5k
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
|The Lancet|1996|1.3k
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
|Nature Genetics|2016|627
Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis
|Nature|2012|599